These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6108019)

  • 1. [Effect of obsidan on the dynamics of the myocardial infarct zone in the 1st days of the disease].
    Ivanova LK
    Vrach Delo; 1980 Oct; (10):15-8. PubMed ID: 6108019
    [No Abstract]   [Full Text] [Related]  

  • 2. [Inderal in the acute and post-myocardial infarct periods].
    Popov VG; Martynov IV; Alushkov MV; Voronin VA
    Ter Arkh; 1986; 58(6):53-8. PubMed ID: 3764715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effectiveness of beta-adrenoblockaders in myocardial infarct].
    Korabel'shchikova NI; Kashshai AA; Pichkar' II
    Vrach Delo; 1981 Dec; (12):38-41. PubMed ID: 6120597
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hemodynamic reactions to the use of beta-adrenoblockaders in acute myocardial infarct].
    Golikov AP; Maĭorov NI; Vaniev SB; Orlov AI
    Vrach Delo; 1980 Nov; (11):33-5. PubMed ID: 6110282
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evaluation of the effects of a beta-blocking drug (moprolol) on hemodynamics and lesion potentials in acute myocardial infarct].
    De Ambroggi L; Perotta GM; Satolli R; Lotto A
    Boll Soc Ital Cardiol; 1977; 22(8):1343-51. PubMed ID: 36116
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experience with using obzidan in myocardial infarct].
    Kuznetsov GP; Gligan LI; Zil'berman ES; Gubanova TG; Fel'dman MS
    Klin Med (Mosk); 1984 Mar; 62(3):35-8. PubMed ID: 6716927
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of beta blockers on the parameters of acute phase response and level of circulating immune complexes in myocardial infarct].
    Korochkin IM; Chukaeva II; Aleshkin AV; Smolina NV; Litvinova SN; Aleksandrov AA
    Sov Med; 1991; (6):45-7. PubMed ID: 1716007
    [No Abstract]   [Full Text] [Related]  

  • 8. [Improved prognosis using beta blockers after myocardial infarct?].
    Weisswange A
    Lebensversicher Med; 1984 Jan; 36(1):14-9. PubMed ID: 6141479
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of obzidan on cell membrane permeability in myocardial infarct patients].
    Parkhomenko AN; Netiazhenko VZ; Angelutsa PA
    Vrach Delo; 1985 Aug; (8):16-9. PubMed ID: 4072104
    [No Abstract]   [Full Text] [Related]  

  • 10. [Beta blockage after myocardial infarct].
    Frick MH; Katila M
    Duodecim; 1982; 98(2):150-7. PubMed ID: 6120827
    [No Abstract]   [Full Text] [Related]  

  • 11. [Mechanisms of the effect of obsidan on the clinical picture of myocardial infarction at the early stage of the disease].
    Andriushchenko OM
    Klin Med (Mosk); 1989 Oct; 67(10):48-51. PubMed ID: 2615306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of beta-adrenolytic drugs on the survival of patients after myocardial infarction].
    Halawa B; Mazurek W
    Wiad Lek; 1986 Jan; 39(1):25-30. PubMed ID: 2872756
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic potential of beta-receptor blockers in acute anterior wall infarct].
    Jentsch G
    MMW Munch Med Wochenschr; 1982 Jun; 124(22):543-4. PubMed ID: 6124886
    [No Abstract]   [Full Text] [Related]  

  • 14. [Epidural analgesia with obzidan in the acute period of myocardial infarct].
    Parkhomenko AN; Netiazhenko VZ; Sirenko IuN
    Vrach Delo; 1989 Dec; (12):10-3. PubMed ID: 2629262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of beta adrenergic blocking agents in the management of the patient with acute myocardial infarction.
    Arensberg D
    Prim Care; 1981 Sep; 8(3):461-6. PubMed ID: 6118904
    [No Abstract]   [Full Text] [Related]  

  • 16. [Obzidan inhibition of lipid free-radical peroxidation in coronary-occluding myocardial infarct].
    Luk'ianova LO; Kudrin AN; Kogan AKh
    Farmakol Toksikol; 1983; 46(1):45-8. PubMed ID: 6825817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The objective assessment of treatment efficacy in microfocal myocardial infarct using paired stress tests].
    Tashchuk VK; Polishchuk OIu; Hrechko SI; Makoviĭchuk IO; Polians'ka OS; Turubarova NA; Chaplyns'kyĭ RB; Sokur IV
    Lik Sprava; 1998 Aug; (6):84-6. PubMed ID: 9844883
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of obzidan in the acute period of myocardial infarct].
    Gvatua NA; Kravtsov VL; Ivanova LK; Shkliar LV; Shumakov VA
    Kardiologiia; 1980 Oct; 20(10):19-24. PubMed ID: 7441957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of labetalol and propranolol in patients who have had a myocardial infarct].
    Il'iash MG; Kravtsova LA; Babov KD; Shcherbak IaIu
    Vrach Delo; 1990 May; (5):26-8. PubMed ID: 2396387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Functional features of acute non-Q-wave myocardial infarction and the influence of pre-hospital treatment with propranalol, heparin and aspirin on the prognosis of the disease].
    Beĭshenkulov MT; Kudaĭbergenova NT; Baltabaev TB
    Klin Med (Mosk); 2005; 83(1):28-32. PubMed ID: 15759487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.